Long-chain MUFAs can also improve obesity-related metabolic dysfunction by upregulation of PPAR-gamma (PPAR-γ) and downregulation of inflammatory markers in the adipose tissue [56]. This evidence concerns the gene PPARG and obesity due to melanocortin 4 receptor deficiency.